Olivier Bouchaud
Inserm(FR)Université Sorbonne Nouvelle(FR)Université de Versailles Saint-Quentin-en-Yvelines(FR)Université Paris-Saclay(FR)Sorbonne Université(FR)Université Sorbonne Paris Nord(FR)Sorbonne Paris Cité(FR)Assistance Publique – Hôpitaux de Paris(FR)Maternité Port Royal(FR)Centre de recherche en Epidémiologie et Santé des Populations(FR)Hôpital Pellegrin(FR)Collaborative Group (United States)(US)Hôpital Robert-Debré(FR)Médecins du Monde(BE)Hôpital Avicenne(FR)Hôpital Jean-Verdier(FR)Hôpital Paul-Brousse(FR)
Publications by Year
Research Areas
Malaria Research and Control, Travel-related health issues, HIV/AIDS Research and Interventions, Mosquito-borne diseases and control, HIV/AIDS drug development and treatment
Most-Cited Works
- → Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials(2018)373 cited
- → Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial(2021)340 cited
- → Tuberculosis in HIV-infected patients: a comprehensive review(2004)332 cited
- → Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study(2014)325 cited
- → High Rate of Acquisition but Short Duration of Carriage of Multidrug-Resistant Enterobacteriaceae After Travel to the Tropics(2015)264 cited